Antimicrobial Susceptibility Testing Market Report By Size, Business Opportunities and Competitive Analysis 2025
The outbreak of COVID-19 has given the global antimicrobial susceptibility testing (AST) market a boost. The upcoming report by Fairfield Market Research states that the market will gain momentum in the coming years as high-throughput AST methods are being used to prevalence of infectious diseases remains on the rise. These are being used to understand the ongoing antimicrobial resistance, which is the biggest challenge for healthcare platforms globally. Antimicrobial susceptibility testing (AST) systems are vital for facilitating the assessment of antibiotic susceptibility and antimicrobial resistance (AMR).
Get a PDF Sample Copy of Antimicrobial Susceptibility Testing Market:
Clinical Diagnostics Leading Application Segment Emerges as Popular Segment Amidst Rising Infections
Initial findings state that clinical diagnostics will lead the way for the market as the segment held a lion’s share in 2020. The high prevalence of infectious diseases has fuelled the demand for use of antimicrobial susceptibility testing for accurate diagnosis. Antibacterial testing became the most popular resistance testing technique system in 2020. This trend is attributable to the stringent guidelines designed specifically to streamline the antimicrobial susceptibility testing process. The growing incidences of infections due to pathogenic bacteria are also expected to contribute to the segment’s expansion.
Growing Antibiotic Resistance Pushes Antimicrobial Susceptibility Testing
According to the global antibiotic statistics, there has been a 35% increase in the consumption of antibiotics between 2000 and 2010. The World Health Organization (WHO) report states that about 700,000 lives per year are lost due to antibiotic resistance. The organization states that the number could reach 10 million per year by 2050. All of these numbers indicate that antibiotic resistance has become a prevalent cause of death. These factors have pushed end users to deploy antimicrobial susceptibility testing for R&D activities and drug discovery.
North America to Pave the Way
Analysts anticipate that North America will dominate the global AST market by the end of 2025. This dominance will be the result of improved access and higher adoption of advanced susceptibility testing methods and products. Investments in research and development are also expected to favour regional market growth.
Meanwhile, Asia Pacific is also expected to grow at a rapid pace. The region will thrive as several AST suppliers are focussing on this region. Affordable labour will continue to be the backbone of the production of AST equipment in the region. India and China will fuel this rise in the coming years. Similarly, emerging economies such as Brazil, Russia, and South Africa will also be the focus area for growth as antibiotic consumption remains high...
Do you already have an account? Log in here